Target lesion revascularisation in patients treated with a sirolimus‐eluting or paclitaxel‐eluting stent

OBJECTIVE: To identify risk factors for clinical‐driven target lesion revascularisation (TLR) in patients treated with sirolimus‐eluting (Cypher) or paclitaxel‐eluting (Taxus) stents in a real‐world scenario. DESIGN: From 1 January 2003 to 18 May 2005, all patients treated with a Cypher or Taxus ste...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maeng, Michael, Jensen, Lisette Okkels, Rasmussen, Klaus, Lassen, Jens Flensted, Krusell, Lars Romer, Thayssen, Per, Thuesen, Leif
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2007
Materias:
Interventional Cardiology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955176/
https://ncbi.nlm.nih.gov/pubmed/17194711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.100594
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares